Jinfo Blog
Receive these Blog items monthly, by signing up for the free newsletter:
Talent management, legal news cut, generative AI developments and new products
5th September 2023
News and current awareness, GenAI, talent development and pharma and bioscience CI are in all in our sights
2nd August 2023
GenAI developments and competitive intelligence in pharma and biosciences
4th July 2023
News and current awareness survey last call, and insights on AI in the information industry
6th June 2023
Vendor management template, news and current awareness survey, AI
3rd May 2023
Contribute to the news and current awareness survey 2023
2nd May 2023
More effective vendor negotiations
3rd April 2023
The goalposts keep moving…
1st March 2023
What a difference a year makes….
1st February 2023
2023 is turning out to be a very different prospect to 2022. Many information leaders have seen changes in their reporting lines as well as dealing with economic headwinds. This is a particularly difficult combination, so information leaders need to focus on articulating their value and maintaining a positive mindset.
Happy anniversary Jinfo, née FreePint
4th January 2023
25 years, 600 editions, 500 contributors. Jinfo has come a long way, and so has the value of information work. However, information leaders still need to win the war for talent, hold vendors to account, and keep an eye on competitors.
Community session: Legal implications of licensing third party content for GenAI
24th October 2023
"Talent management, legal news cut, generative AI developments and new products"
5th September 2023
Learn about the vital role of nurturing the talent pipeline and succession. There's now a legal cut of our news and current awareness survey. And a real need for information managers to assert themselves to maximise the value of generative AI and mitigate the risks.
Read on the Blog- Talent management, legal news cut, generative AI developments and new products
5th September 2023 - News and current awareness, GenAI, talent development and pharma and bioscience CI are in all in our sights
2nd August 2023 - GenAI developments and competitive intelligence in pharma and biosciences
4th July 2023
- Legal implications of licensing third party content for GenAI (Community) 24th October 2023
- Managing the talent pipeline & succession (Community) 14th September 2023
- The impact of AI – how are vendors responding? (Community) 20th July 2023